EpiCast Report: Endometriosis – Epidemiology Forecast to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3995

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding, and infertility. Endometriosis has the potential to disrupt the quality of life of women, leading to emotional distress, loss of work productivity, physical limitations, and social withdrawal.

This report also provides diagnosed incident and prevalent cases of endometriosis segmented by laparoscopy confirmation status (laparoscopy-confirmed or suspected without laparoscopy). The laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further classified according to endometriosis staging system developed by the American Society for Reproductive Medicine (ASRM) into stage I (minimal), stage II (mild), stage III (moderate), and stage IV (severe). In addition, the laparoscopy-confirmed diagnosed prevalent cases of endometriosis are segmented by phenotypes into superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deeply infiltrating endometriosis (DIE). The laparoscopy-confirmed diagnosed incident and laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further segmented by age.

In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed incident cases of endometriosis will increase from 251,010 cases in 2015 to 253,620 cases in 2025 at an Annual Growth Rate (AGR) of 0.10%. In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed prevalent cases of endometriosis will increase from 6,160,839 cases in 2015 to 6,217,079 cases in 2025 at an AGR of 0.09%.

GlobalData epidemiologists utilized comprehensive, country-specific data from peer-reviewed journal articles, and primary research to arrive at a meaningful, in-depth analysis and forecast for laparoscopy-confirmed diagnosed incident cases of endometriosis, as well as laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Finally, the same forecast methodology was used across the 7MM, thereby allowing for meaningful global comparisons of laparoscopy-confirmed diagnosed incident cases, and laparoscopy-confirmed diagnosed prevalent cases of endometriosis across these markets.

Scope

The Endometriosis EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of endometriosis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the laparoscopy-confirmed diagnosed incident cases of endometriosis and a 10-year forecast of laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Additional segmentations of patient populations are also available.

The endometriosis epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.

The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Epidemiology

2.1Disease Background

2.2Risk Factors and Comorbidities

2.3Global Trends

2.3.1US

2.3.25EU

2.3.3Japan

2.4Forecast Methodology

2.4.1Sources Used Tables

2.4.2Forecast Assumptions and Methods

2.4.3Sources Not Used

2.5Epidemiological Forecast for Endometriosis (2015–2025)

2.5.1Diagnosed Incident Cases

2.5.2Diagnosed Prevalent Cases

2.6Discussion

2.6.1Epidemiological Forecast Insight

2.6.2Limitations of the Analysis

2.6.3Strengths of the Analysis

3Appendix

3.1Bibliography

3.2Physicians and Specialists Included in this Study

3.3About the Authors

1.1.1Epidemiologists

3.3.1Reviewers

3.3.2Global Director of Therapy Analysis and Epidemiology

3.4About GlobalData

3.5About EpiCast

3.6Disclaimer

Table

Table 1: Risk Factors and Comorbidities for Endometriosis

Table 2: Stages of Endometriosis According to the American Society for Reproductive Medicine Criteria

Table 3: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Incident Cases of Endometriosis

Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Prevalent Cases of Endometriosis

Table 5: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the ASRM Stages I–IV

Table 6: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the Phenotype

Table 7: Sources Used to Forecast Laparoscopy Confirmation Status for Diagnosed Incident Cases and Diagnosed Prevalent Cases of Endometriosis

Table 8: 7MM, Sources Not Used in Epidemiological Analysis of Endometriosis

Table 9: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12–54 Years, Women, N, 2015–2025

Table 10: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Women, N (Row %), 2015

Table 11: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12–54 Years, Women, N, 2015–2025

Table 12: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N (Row %), 2015

Table 13: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2016

Figures

Figure 1: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12–54 Years, Women, N, 2015–2025

Figure 2: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis by Age Group, Women, N, 2015

Figure 3: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Incidence of Endometriosis (Cases per 100,000 Population), Ages 12–54 Years, Women, 2015

Figure 4: 7MM, Diagnosed Incident Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12–54 Years, Women, N, 2015

Figure 5: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12–54 Years, Women, N, 2015–2025

Figure 6: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N, 2015

Figure 7: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Prevalence of Endometriosis (%), Ages 12–54 Years, Women, 2015

Figure 8: 7MM, Diagnosed Prevalent Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12–54 Years, Women, N, 2015

Figure 9: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by ASRM Disease Stages, Ages 12–54 Years, Women, N, 2015

Figure 10: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by Phenotype, Ages 12–54 Years, Women, N, 2015

Frequently asked questions

EpiCast Report: Endometriosis – Epidemiology Forecast to 2025 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EpiCast Report: Endometriosis – Epidemiology Forecast to 2025 in real time.

  • Access a live EpiCast Report: Endometriosis – Epidemiology Forecast to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.